VanCott et al., 1994 - Google Patents

Serotyping international HIV-1 isolates by V3 peptides and whole gp160 proteins using BIAcore

VanCott et al., 1994

Document ID
15204771123871237861
Author
VanCott T
Bethke F
Artenstein A
McCutchan F
McNeil J
Mascola J
Redfield R
Birx D
Publication year
Publication venue
Methods

External Links

Snippet

There are at present at least seven distinct genotypes of HIV-1 worldwide, with as much as 30% variation in DNA sequence between genotypes. Within each genotype family (clade) there is 15-20% diversity, whereas within a single HIV-1-infected individual there is …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—AIDS or HTLV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/543—Immunoassay; Biospecific binding assay with an insoluble carrier for immobilising immunochemicals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse Transcribing RNA Viruses
    • C12N2740/00011—Reverse Transcribing RNA Viruses
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses

Similar Documents

Publication Publication Date Title
Moore et al. A human monoclonal antibody to a complex epitope in the V3 region of gp120 of human immunodeficiency virus type 1 has broad reactivity within and outside clade B
VanCott et al. Dissociation rate of antibody-gp120 binding interactions is predictive of V3-mediated neutralization of HIV-1.
Xu et al. Epitope mapping of two immunodominant domains of gp41, the transmembrane protein of human immunodeficiency virus type 1, using ten human monoclonal antibodies
AU2009213045B2 (en) Nucleotide sequences of HIV-1 type (or subtype) O retrovirus antigens
Wahren et al. HIV-1 peptides induce a proliferative response in lymphocytes from infected persons
Richardson Jr et al. Humoral response to oligomeric human immunodeficiency virus type 1 envelope protein
CA2005955C (en) Synthetic hiv-like peptides, their compositions and uses
Hinkula et al. Epitope mapping of the HIV-1 gag region with monoclonal antibodies
VanCott et al. Serotyping international HIV-1 isolates by V3 peptides and whole gp160 proteins using BIAcore
JP3271666B2 (en) Discrimination between antibodies against HTLV-I, HTLV-II or related retrovirus, detection of novel peptides, antibodies and immunoassay kit
VanCott et al. Characterization of a soluble, oligomeric HIV-1 gp160 protein as a potential immunogen
Richalet-Sécordel et al. Cross-reactive potential of rabbit antibodies raised against a cyclic peptide representing a chimeric V3 loop of HIV-1 gp120 studied by biosensor technique and ELISA
AU641554B2 (en) Novel peptide antigens and immunoassays, test kits and vaccines using the same
US6818219B1 (en) Reagent for detecting and monitoring viral infections
AU642886B2 (en) T-lymphotropic retrovirus monoclonal antibodies
Lal et al. Identification of immunodominant epitopes in envelope glycoprotein of human T lymphotropic virus type II
Polonis et al. HIV type 1 subtype E-infected patients with broadened, dual (B/E) V3 loop serology have increased cross-neutralizing antibodies
Marin et al. Chimeric synthetic peptides from the envelope (gp46) and the transmembrane (gp21) glycoproteins for the detection of antibodies to human T-cell leukemia virus type II
JPH08509597A (en) HTLV- [I] and HTLV- [II] GP21-derived peptides for use in diagnosis
AU621855B2 (en) Peptide corresponding to hiv-env 583-599, and analogs thereof and applications of the peptides
AU617201B2 (en) Novel protein and coding sequence for detection and differentiation of siv and hiv-2 group of viruses
US6218102B1 (en) Synthetic peptides and mixtures thereof for detecting HIV antibodies
KR100254811B1 (en) A novel nomoclonal antibody specific for hiv-1 capsid protein p24, its hybridoma cell line and process for preparation thereof
CA2676762C (en) Peptides for the detection of hiv-1 group o
AU780017B2 (en) Nucleotide sequences of HIV-1 type (or subtype) O retrovirus antigens